Medidata Launches Groundbreaking Sensor Cloud Network to Connect Digital Health Innovators

  • Medidata’s new Network connects top innovators for data sharing, self-service sensor integration, digital biomarker development/discovery and collaboration
  • Cutting edge tools, technology and training enable discovery and delivery of third-party algorithms at scale

New York – October 6, 2021 -- Medidata, a Dassault Systèmes company, today announced the launch of Medidata Sensor Cloud Network at NEXT Global 2021. The Medidata Sensor Cloud Network will create the first industry-wide collaboration amongst contract research organizations (CROs), device manufacturers, drug and vaccine developers, analytics companies, and academia focused on solving challenges related to sensor integrations, standardization of sensor data, and the development of digital biomarkers and algorithms. This collaborative environment and approach is unique in its ability to connect to the Medidata Sensor Cloud, which provides the ability to ingest, normalize, and analyze data into a common format.

“The most important innovations in healthcare will come from interdisciplinary collaboration. The Medidata Sensor Cloud Network is intended to provide structure and technology enablement to bring exciting new innovations to market even faster,” said Anthony Costello, CEO of Patient Cloud at Dassault Systèmes. “We’re excited to see how our collaborators will utilize this unique offering to bring the next generation of care to patients.”

Following the launch of Medidata’s Sensor Cloud and Labcorp Drug Development’s recent adoption of the offering, researchers, data scientists, engineers, and clinicians have been sharing data sets, working together on similar projects, breaking down information silos and helping each other develop new insights and algorithms in an accelerated manner. Breakthroughs from these collaborations will help optimize patient care through better treatments and interventions, improve outcomes and decrease healthcare and clinical trial costs. The Medidata Sensor Cloud Network will also accelerate new partnerships between sensor companies, increasing the number of medical grade data streams available for clinical researchers. 

Medidata is offering stakeholders training modules in the areas of sensor integrations, data analytics, clinical operations, enablement and a wealth of information sharing guidelines to facilitate distributed, curated collaboration from thought leaders. Additionally the Medidata Sensor Cloud Network includes development tools that will allow data scientists to refine, test and deliver physiological algorithms with clinical meaning at scale. Examples include refined motion parameters like gait, cardiovascular insights and advanced sleep metrics.  

To stimulate early collaboration in the Medidata Sensor Cloud Network, Medidata will be sponsoring a Hackathon Challenge with sensor data sets that will be made available to participants. This event is intended to tackle some of the toughest questions in both the use and utility of sensor data in clinical research settings. Details on this event may be found here.
 
Medidata is a wholly owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.

About Medidata

Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. With over 20 years of groundbreaking technological innovation across more than 30,000 trials and 9 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across 2,100+ customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. The company is a wholly owned subsidiary of Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA), which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization. Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata,

About Dassault Systèmes

Dassault Systèmes, the 3DEXPERIENCE® Company, is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all – consumers, patients and citizens. Dassault Systèmes brings value to more than 300,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit https://www.3ds.com